ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 194 filers reported holding ARRAY BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $7,079,000 | +145.8% | 152,795 | +29.3% | 0.32% | +183.8% |
| Q1 2019 | $2,880,000 | +65.9% | 118,145 | +14.2% | 0.11% | +109.4% |
| Q2 2018 | $1,736,000 | +6.0% | 103,465 | +3.2% | 0.05% | +1.9% |
| Q1 2018 | $1,637,000 | -39.7% | 100,300 | -54.6% | 0.05% | -39.5% |
| Q3 2017 | $2,717,000 | +14.4% | 220,907 | -22.1% | 0.09% | +34.4% |
| Q2 2017 | $2,374,000 | -35.8% | 283,667 | -31.4% | 0.06% | -39.6% |
| Q1 2017 | $3,697,000 | -21.1% | 413,530 | -22.4% | 0.11% | -15.2% |
| Q4 2016 | $4,685,000 | +42.9% | 533,000 | +9.7% | 0.12% | +37.4% |
| Q3 2016 | $3,279,000 | +66.0% | 485,780 | -12.5% | 0.09% | +56.9% |
| Q2 2016 | $1,975,000 | +6483.3% | 554,890 | +5345.4% | 0.06% | +5700.0% |
| Q1 2016 | $30,000 | -30.2% | 10,190 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $43,000 | -8.5% | 10,190 | -1.8% | 0.00% | 0.0% |
| Q3 2015 | $47,000 | -25.4% | 10,380 | -17.5% | 0.00% | -50.0% |
| Q4 2013 | $63,000 | -20.3% | 12,575 | -1.8% | 0.00% | 0.0% |
| Q3 2013 | $79,000 | – | 12,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,459,128 | $234,543,000 | 9.43% |
| APIS CAPITAL ADVISORS, LLC | 490,000 | $6,983,000 | 9.36% |
| BVF INC/IL | 4,744,062 | $67,603,000 | 8.84% |
| First Light Asset Management, LLC | 2,853,826 | $40,667,000 | 6.48% |
| SECTORAL ASSET MANAGEMENT INC | 2,165,767 | $30,862,000 | 4.20% |
| GREAT POINT PARTNERS LLC | 1,850,000 | $26,363,000 | 3.33% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 146,952 | $2,092,000 | 2.46% |
| Birchview Capital, LP | 168,000 | $2,394,000 | 2.26% |
| X-Square Capital, LLC | 180,554 | $2,572,000 | 2.02% |
| FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD | 295,610 | $4,212,000 | 1.54% |